The global Liver Diseases Therapeutics Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Liver Diseases Therapeutics Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Liver Diseases Therapeutics Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Liver Diseases Therapeutics Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Liver Diseases Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Diseases Therapeutics Drugs. This report contains market size and forecasts of Liver Diseases Therapeutics Drugs in global, including the following market information:
- Global Liver Diseases Therapeutics Drugs Market Revenue, 2019-2024, 2024-2029, ($ millions)
- Global Liver Diseases Therapeutics Drugs Market Sales, 2019-2024, 2024-2029, (K Pcs)
- Global top five Liver Diseases Therapeutics Drugs companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oral Liver Diseases Therapeutics Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Liver Diseases Therapeutics Drugs include F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Achillion Pharmaceuticals, AbbVie, Angion Biomedica and Bayer, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liver Diseases Therapeutics Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liver Diseases Therapeutics Drugs Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Liver Diseases Therapeutics Drugs Market Segment Percentages, by Type, 2023 (%)
- Oral Liver Diseases Therapeutics Drugs
- Injection Liver Diseases Therapeutics Drugs
Global Liver Diseases Therapeutics Drugs Market, by Application, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Liver Diseases Therapeutics Drugs Market Segment Percentages, by Application, 2023 (%)
Global Liver Diseases Therapeutics Drugs Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Liver Diseases Therapeutics Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Liver Diseases Therapeutics Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Liver Diseases Therapeutics Drugs revenues share in global market, 2023 (%)
- Key companies Liver Diseases Therapeutics Drugs sales in global market, 2019-2024 (Estimated), (K Pcs)
- Key companies Liver Diseases Therapeutics Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- F. Hoffmann-La Roche
- Gilead Sciences
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Achillion Pharmaceuticals
- AbbVie
- Angion Biomedica
- Bayer
- LG Life Sciences
- Phenex Pharmaceuticals
- ProMetic Life Sciences
- Raptor Pharmaceuticals
- Shenzhen Kangtai Biological Products
- Verva Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liver Diseases Therapeutics Drugs, market overview.
Chapter 2: Global Liver Diseases Therapeutics Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Liver Diseases Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liver Diseases Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Liver Diseases Therapeutics Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liver Diseases Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liver Diseases Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liver Diseases Therapeutics Drugs Overall Market Size
2.1 Global Liver Diseases Therapeutics Drugs Market Size: 2022 VS 2031
2.2 Global Liver Diseases Therapeutics Drugs Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Liver Diseases Therapeutics Drugs Sales: 2019-2031
3 Company Landscape
3.1 Top Liver Diseases Therapeutics Drugs Players in Global Market
3.2 Top Global Liver Diseases Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Liver Diseases Therapeutics Drugs Revenue by Companies
3.4 Global Liver Diseases Therapeutics Drugs Sales by Companies
3.5 Global Liver Diseases Therapeutics Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Liver Diseases Therapeutics Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Liver Diseases Therapeutics Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liver Diseases Therapeutics Drugs Players in Global Market
3.8.1 List of Global Tier 1 Liver Diseases Therapeutics Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Liver Diseases Therapeutics Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Liver Diseases Therapeutics Drugs Market Size Markets, 2022 & 2031
4.1.2 Oral Liver Diseases Therapeutics Drugs
4.1.3 Injection Liver Diseases Therapeutics Drugs
4.2 By Type - Global Liver Diseases Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Liver Diseases Therapeutics Drugs Revenue, 2019-2024
4.2.2 By Type - Global Liver Diseases Therapeutics Drugs Revenue, 2024-2031
4.2.3 By Type - Global Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
4.3 By Type - Global Liver Diseases Therapeutics Drugs Sales & Forecasts
4.3.1 By Type - Global Liver Diseases Therapeutics Drugs Sales, 2019-2024
4.3.2 By Type - Global Liver Diseases Therapeutics Drugs Sales, 2024-2031
4.3.3 By Type - Global Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
4.4 By Type - Global Liver Diseases Therapeutics Drugs Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liver Diseases Therapeutics Drugs Market Size, 2022 & 2031
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Liver Diseases Therapeutics Drugs Revenue & Forecasts
5.2.1 By Application - Global Liver Diseases Therapeutics Drugs Revenue, 2019-2024
5.2.2 By Application - Global Liver Diseases Therapeutics Drugs Revenue, 2024-2031
5.2.3 By Application - Global Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
5.3 By Application - Global Liver Diseases Therapeutics Drugs Sales & Forecasts
5.3.1 By Application - Global Liver Diseases Therapeutics Drugs Sales, 2019-2024
5.3.2 By Application - Global Liver Diseases Therapeutics Drugs Sales, 2024-2031
5.3.3 By Application - Global Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
5.4 By Application - Global Liver Diseases Therapeutics Drugs Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Liver Diseases Therapeutics Drugs Market Size, 2022 & 2031
6.2 By Region - Global Liver Diseases Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Liver Diseases Therapeutics Drugs Revenue, 2019-2024
6.2.2 By Region - Global Liver Diseases Therapeutics Drugs Revenue, 2024-2031
6.2.3 By Region - Global Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
6.3 By Region - Global Liver Diseases Therapeutics Drugs Sales & Forecasts
6.3.1 By Region - Global Liver Diseases Therapeutics Drugs Sales, 2019-2024
6.3.2 By Region - Global Liver Diseases Therapeutics Drugs Sales, 2024-2031
6.3.3 By Region - Global Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Liver Diseases Therapeutics Drugs Revenue, 2019-2031
6.4.2 By Country - North America Liver Diseases Therapeutics Drugs Sales, 2019-2031
6.4.3 US Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.4.4 Canada Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.4.5 Mexico Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Liver Diseases Therapeutics Drugs Revenue, 2019-2031
6.5.2 By Country - Europe Liver Diseases Therapeutics Drugs Sales, 2019-2031
6.5.3 Germany Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.5.4 France Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.5.5 U.K. Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.5.6 Italy Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.5.7 Russia Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.5.8 Nordic Countries Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.5.9 Benelux Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Liver Diseases Therapeutics Drugs Revenue, 2019-2031
6.6.2 By Region - Asia Liver Diseases Therapeutics Drugs Sales, 2019-2031
6.6.3 China Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.6.4 Japan Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.6.5 South Korea Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.6.6 Southeast Asia Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.6.7 India Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Liver Diseases Therapeutics Drugs Revenue, 2019-2031
6.7.2 By Country - South America Liver Diseases Therapeutics Drugs Sales, 2019-2031
6.7.3 Brazil Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.7.4 Argentina Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liver Diseases Therapeutics Drugs Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Liver Diseases Therapeutics Drugs Sales, 2019-2031
6.8.3 Turkey Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.8.4 Israel Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.8.5 Saudi Arabia Liver Diseases Therapeutics Drugs Market Size, 2019-2031
6.8.6 UAE Liver Diseases Therapeutics Drugs Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Company Summary
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Major Product Offerings
7.1.4 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.1.5 F. Hoffmann-La Roche Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Liver Diseases Therapeutics Drugs Major Product Offerings
7.2.4 Gilead Sciences Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Major Product Offerings
7.3.4 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Major Product Offerings
7.4.4 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Liver Diseases Therapeutics Drugs Major Product Offerings
7.5.4 Merck Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Merck Key News & Latest Developments
7.6 Achillion Pharmaceuticals
7.6.1 Achillion Pharmaceuticals Company Summary
7.6.2 Achillion Pharmaceuticals Business Overview
7.6.3 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Major Product Offerings
7.6.4 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Achillion Pharmaceuticals Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Liver Diseases Therapeutics Drugs Major Product Offerings
7.7.4 AbbVie Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.7.5 AbbVie Key News & Latest Developments
7.8 Angion Biomedica
7.8.1 Angion Biomedica Company Summary
7.8.2 Angion Biomedica Business Overview
7.8.3 Angion Biomedica Liver Diseases Therapeutics Drugs Major Product Offerings
7.8.4 Angion Biomedica Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Angion Biomedica Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Liver Diseases Therapeutics Drugs Major Product Offerings
7.9.4 Bayer Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Bayer Key News & Latest Developments
7.10 LG Life Sciences
7.10.1 LG Life Sciences Company Summary
7.10.2 LG Life Sciences Business Overview
7.10.3 LG Life Sciences Liver Diseases Therapeutics Drugs Major Product Offerings
7.10.4 LG Life Sciences Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.10.5 LG Life Sciences Key News & Latest Developments
7.11 Phenex Pharmaceuticals
7.11.1 Phenex Pharmaceuticals Company Summary
7.11.2 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Business Overview
7.11.3 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Major Product Offerings
7.11.4 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Phenex Pharmaceuticals Key News & Latest Developments
7.12 ProMetic Life Sciences
7.12.1 ProMetic Life Sciences Company Summary
7.12.2 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Business Overview
7.12.3 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Major Product Offerings
7.12.4 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.12.5 ProMetic Life Sciences Key News & Latest Developments
7.13 Raptor Pharmaceuticals
7.13.1 Raptor Pharmaceuticals Company Summary
7.13.2 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Business Overview
7.13.3 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Major Product Offerings
7.13.4 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.13.5 Raptor Pharmaceuticals Key News & Latest Developments
7.14 Shenzhen Kangtai Biological Products
7.14.1 Shenzhen Kangtai Biological Products Company Summary
7.14.2 Shenzhen Kangtai Biological Products Business Overview
7.14.3 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Major Product Offerings
7.14.4 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.14.5 Shenzhen Kangtai Biological Products Key News & Latest Developments
7.15 Verva Pharmaceuticals
7.15.1 Verva Pharmaceuticals Company Summary
7.15.2 Verva Pharmaceuticals Business Overview
7.15.3 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Major Product Offerings
7.15.4 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.15.5 Verva Pharmaceuticals Key News & Latest Developments
8 Global Liver Diseases Therapeutics Drugs Production Capacity, Analysis
8.1 Global Liver Diseases Therapeutics Drugs Production Capacity, 2019-2031
8.2 Liver Diseases Therapeutics Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Liver Diseases Therapeutics Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liver Diseases Therapeutics Drugs Supply Chain Analysis
10.1 Liver Diseases Therapeutics Drugs Industry Value Chain
10.2 Liver Diseases Therapeutics Drugs Upstream Market
10.3 Liver Diseases Therapeutics Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liver Diseases Therapeutics Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Liver Diseases Therapeutics Drugs in Global Market
Table 2. Top Liver Diseases Therapeutics Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Liver Diseases Therapeutics Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Liver Diseases Therapeutics Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Liver Diseases Therapeutics Drugs Sales by Companies, (K Pcs), 2019-2024
Table 6. Global Liver Diseases Therapeutics Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Liver Diseases Therapeutics Drugs Price (2019-2024) & (USD/Pcs)
Table 8. Global Manufacturers Liver Diseases Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Liver Diseases Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liver Diseases Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Liver Diseases Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Liver Diseases Therapeutics Drugs Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Liver Diseases Therapeutics Drugs Sales (K Pcs), 2019-2024
Table 15. By Type - Global Liver Diseases Therapeutics Drugs Sales (K Pcs), 2024-2031
Table 16. By Application ? Global Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Table 17. By Application - Global Liver Diseases Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Liver Diseases Therapeutics Drugs Revenue (US$, Mn), 2024-2031
Table 19. By Application - Global Liver Diseases Therapeutics Drugs Sales (K Pcs), 2019-2024
Table 20. By Application - Global Liver Diseases Therapeutics Drugs Sales (K Pcs), 2024-2031
Table 21. By Region ? Global Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Liver Diseases Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Liver Diseases Therapeutics Drugs Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Liver Diseases Therapeutics Drugs Sales (K Pcs), 2019-2024
Table 25. By Region - Global Liver Diseases Therapeutics Drugs Sales (K Pcs), 2024-2031
Table 26. By Country - North America Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 29. By Country - North America Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 30. By Country - Europe Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 33. By Country - Europe Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 34. By Region - Asia Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 37. By Region - Asia Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 38. By Country - South America Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 41. By Country - South America Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 42. By Country - Middle East & Africa Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 45. By Country - Middle East & Africa Liver Diseases Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 46. F. Hoffmann-La Roche Company Summary
Table 47. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Offerings
Table 48. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 49. F. Hoffmann-La Roche Key News & Latest Developments
Table 50. Gilead Sciences Company Summary
Table 51. Gilead Sciences Liver Diseases Therapeutics Drugs Product Offerings
Table 52. Gilead Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 53. Gilead Sciences Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Offerings
Table 56. GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Liver Diseases Therapeutics Drugs Product Offerings
Table 60. Johnson & Johnson Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Liver Diseases Therapeutics Drugs Product Offerings
Table 64. Merck Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 65. Merck Key News & Latest Developments
Table 66. Achillion Pharmaceuticals Company Summary
Table 67. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Offerings
Table 68. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 69. Achillion Pharmaceuticals Key News & Latest Developments
Table 70. AbbVie Company Summary
Table 71. AbbVie Liver Diseases Therapeutics Drugs Product Offerings
Table 72. AbbVie Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 73. AbbVie Key News & Latest Developments
Table 74. Angion Biomedica Company Summary
Table 75. Angion Biomedica Liver Diseases Therapeutics Drugs Product Offerings
Table 76. Angion Biomedica Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 77. Angion Biomedica Key News & Latest Developments
Table 78. Bayer Company Summary
Table 79. Bayer Liver Diseases Therapeutics Drugs Product Offerings
Table 80. Bayer Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 81. Bayer Key News & Latest Developments
Table 82. LG Life Sciences Company Summary
Table 83. LG Life Sciences Liver Diseases Therapeutics Drugs Product Offerings
Table 84. LG Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 85. LG Life Sciences Key News & Latest Developments
Table 86. Phenex Pharmaceuticals Company Summary
Table 87. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Offerings
Table 88. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 89. Phenex Pharmaceuticals Key News & Latest Developments
Table 90. ProMetic Life Sciences Company Summary
Table 91. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Offerings
Table 92. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 93. ProMetic Life Sciences Key News & Latest Developments
Table 94. Raptor Pharmaceuticals Company Summary
Table 95. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Offerings
Table 96. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 97. Raptor Pharmaceuticals Key News & Latest Developments
Table 98. Shenzhen Kangtai Biological Products Company Summary
Table 99. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Offerings
Table 100. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 101. Shenzhen Kangtai Biological Products Key News & Latest Developments
Table 102. Verva Pharmaceuticals Company Summary
Table 103. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Offerings
Table 104. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 105. Verva Pharmaceuticals Key News & Latest Developments
Table 106. Liver Diseases Therapeutics Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2024 (K Pcs)
Table 107. Global Liver Diseases Therapeutics Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Liver Diseases Therapeutics Drugs Production by Region, 2019-2024 (K Pcs)
Table 109. Global Liver Diseases Therapeutics Drugs Production by Region, 2024-2031 (K Pcs)
Table 110. Liver Diseases Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 111. Liver Diseases Therapeutics Drugs Market Drivers in Global Market
Table 112. Liver Diseases Therapeutics Drugs Market Restraints in Global Market
Table 113. Liver Diseases Therapeutics Drugs Raw Materials
Table 114. Liver Diseases Therapeutics Drugs Raw Materials Suppliers in Global Market
Table 115. Typical Liver Diseases Therapeutics Drugs Downstream
Table 116. Liver Diseases Therapeutics Drugs Downstream Clients in Global Market
Table 117. Liver Diseases Therapeutics Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Liver Diseases Therapeutics Drugs Segment by Type in 2022
Figure 2. Liver Diseases Therapeutics Drugs Segment by Application in 2022
Figure 3. Global Liver Diseases Therapeutics Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liver Diseases Therapeutics Drugs Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Liver Diseases Therapeutics Drugs Revenue, 2019-2031 (US$, Mn)
Figure 7. Liver Diseases Therapeutics Drugs Sales in Global Market: 2019-2031 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Liver Diseases Therapeutics Drugs Revenue in 2022
Figure 9. By Type - Global Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 11. By Type - Global Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
Figure 12. By Type - Global Liver Diseases Therapeutics Drugs Price (USD/Pcs), 2019-2031
Figure 13. By Application - Global Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Application - Global Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 15. By Application - Global Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
Figure 16. By Application - Global Liver Diseases Therapeutics Drugs Price (USD/Pcs), 2019-2031
Figure 17. By Region - Global Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Liver Diseases Therapeutics Drugs Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 20. By Region - Global Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
Figure 21. By Country - North America Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 22. By Country - North America Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
Figure 23. US Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
Figure 28. Germany Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 29. France Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
Figure 37. China Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 41. India Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 43. By Country - South America Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
Figure 44. Brazil Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Liver Diseases Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Liver Diseases Therapeutics Drugs Sales Market Share, 2019-2031
Figure 48. Turkey Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Liver Diseases Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 52. Global Liver Diseases Therapeutics Drugs Production Capacity (K Pcs), 2019-2031
Figure 53. The Percentage of Production Liver Diseases Therapeutics Drugs by Region, 2022 VS 2031
Figure 54. Liver Diseases Therapeutics Drugs Industry Value Chain
Figure 55. Marketing Channels
